Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $305.5M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Perspective Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
2 insiders, $1.62M in total
Insiders trading
2
Net value
−$1.62M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Perspective Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Perspective Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Lantheus Holdings, Inc.10% Owner11,273,364Sep 8, 20264
Lantheus Alpha Therapy, LLC10% Owner11,273,364Sep 8, 20263
Henson HeidiDirector25,975IndirectMar 4, 20261
Hunt Jonathan RobertChief Accounting Officer59,800Mar 4, 20262
Woods Lori ADirector183,460IndirectMar 4, 20261
Williamson Robert F IIIDirector9,864IndirectMar 4, 20262
Spoor Johan M.Chief Executive Officer4,650IndirectMar 4, 20261
Morich FrankDirector–Mar 4, 20261
Martinez Maria EDirector–Mar 4, 20261
Puhlmann MarkusChief Medical Officer1,375,425Mar 4, 20261
Sendek JoelChief Financial Officer–Sep 5, 20250
Graham JuanChief Financial Officer35,354Apr 1, 20250
Austin Mark JohnVP Finance/Prin Fin&Acct Offic84,030Jul 19, 20240
Streeter JenniferCOO & VP of HR77,940Jun 14, 20230
McCormick Michael WDirector–Feb 23, 20230
Cavanagh WilliamChief R&D Officer–Aug 1, 20220
Vitale Philip JDirector–Jul 28, 20220
Hoffmann AlanDirector–Jul 28, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 8, 2026 (view filing)4:51 PM ETSep 3-45 daysLantheus Holdings, Inc. and 1 other10% OwnerSSale−247.9K$3.13−$776.9K−2.2%11.3M after2 lots
Sep 4, 2026 (view filing)5:00 PM ETSep 22 daysLantheus Holdings, Inc. and 1 other10% OwnerSSale−42.1K$3.11−$131.2K−0.4%11.5M after
Sep 4, 2026 (view filing)4:58 PM ETAug 31-Sep 14 daysLateLantheus Alpha Therapy, LLC10% OwnerSSale−113.9K$3.14−$357.2K−1.0%11.6M after2 lots
Sep 3, 2026 (view filing)4:54 PM ETSep 12 daysLantheus Holdings, Inc.10% OwnerSSale−35.8K$3.12−$111.6K−0.3%11.6M after
Sep 2, 2026 (view filing)4:36 PM ETAug 312 daysLantheus Holdings, Inc.10% OwnerSSale−78.1K$3.14−$245.6K−0.7%11.6M after
Nov 17, 2025 (view filing)Nov 134 daysHunt Jonathan RobertChief Accounting OfficerPPurchase+11.0K$2.03+$22.3K+22.5%59.8K after
Nov 14, 2025 (view filing)Nov 122 daysWilliamson Robert F IIIDirectorPPurchase+9.50K$2.10+$19.9K+2,595.1%9.86K after
Apr 1, 2025 (view filing)Mar 284 daysSpoor Johan M.Chief Executive OfficerPPurchase+22.0K$2.24+$49.3K+59.0%59.4K after
Apr 1, 2025 (view filing)Mar 284 daysSpoor Johan M.Chief Executive OfficerPPurchase+4.65K$2.21+$10.3KNew position4.65K after
Apr 1, 2025 (view filing)Mar 28-314 daysWilliamson Robert F IIIDirectorPPurchase+60.3K$2.19+$132.0K+124.0%109.0K after2 lots
Apr 1, 2025 (view filing)Mar 284 daysGraham JuanChief Financial OfficerPPurchase+33.3K$2.25+$75.0K+1,649.3%35.4K after
Apr 1, 2025 (view filing)Mar 311 dayWoods Lori ADirectorPPurchase+23.5K$2.13+$50.0K+14.7%183.5K after
Dec 6, 2024 (view filing)Dec 42 daysHenson HeidiDirectorPPurchase+26.0K$3.85+$100.0KNew position26.0K after
Dec 4, 2024 (view filing)Dec 4Same daySpoor Johan M.CEOPPurchase+8.00K$3.77+$30.2K+28.3%36.3K after
Nov 27, 2024 (view filing)Nov 252 daysHunt Jonathan RobertChief Financial OfficerPPurchase+12.8K$3.82+$49.0K+35.7%48.8K after4 lots
Jun 18, 2024 (view filing)Jun 171 dayHunt Jonathan RobertChief Financial OfficerPPurchase+1.80K$9.82+$17.7K+5.3%36.0K after
Jun 18, 2024 (view filing)Jun 144 daysWoods Lori ADirectorPPurchase+4.59K$10.90+$50.0K+3.0%160.0K after2 lots
Jun 13, 2024 (view filing)Jun 13Same daySpoor Johan M.CEOPPurchase+100.0K$1.17+$117.0K+266.2%137.6K after
Jun 3, 2024 (view filing)May 313 daysHunt Jonathan RobertChief Financial OfficerPPurchase+25.0K$1.40+$35.0K+7.9%341.7K after2 lots
Jun 3, 2024 (view filing)May 313 daysWilliamson Robert F IIIDirectorPPurchase+55.0K$1.38+$75.9K+14.9%423.8K after
May 30, 2024 (view filing)May 291 dayWilliamson Robert F IIIDirectorPPurchase+30.0K$1.33+$40.0K+8.9%368.8K after2 lots
Mar 8, 2024 (view filing)11:24 AM ETMar 62 daysLantheus Holdings, Inc. and 1 other10% OwnerPPurchase+60.4M$0.95+$57.4M+107.3%116.8M after10b5-1
Feb 1, 2024 (view filing)Jan 302 daysWilliamson Robert F IIIDirectorPPurchase+127.2K$0.7131+$90.7K+60.1%338.8K after5 lots
Jan 30, 2024 (view filing)Jan 26-294 daysWilliamson Robert F IIIDirectorPPurchase+135.9K$0.5775+$78.5K+179.6%211.6K after7 lots
Jan 26, 2024 (view filing)5:38 PM ETJan 24-252 daysWilliamson Robert F IIIDirectorPPurchase+52.0K$0.49+$25.5K+219.6%75.7K after2 lots
Jan 26, 2024 (view filing)Jan 242 daysPuhlmann MarkusChief Medical OfficerPPurchase+280.0K$0.50+$140.0K+25.6%1.38M after
Dec 26, 2023 (view filing)5:00 PM ETDec 215 daysWilliamson Robert F IIIDirectorPPurchase+3.66K$0.3283+$1.20KNew position3.66K after
Dec 19, 2023 (view filing)7:11 PM ETDec 181 dayHunt Jonathan RobertChief Financial OfficerPPurchase+125.0K$0.2587+$32.3K+65.2%316.7K after
Dec 19, 2023 (view filing)7:10 PM ETDec 18-191 dayWilliamson Robert F IIIDirectorPPurchase+23.7K$0.2947+$6.98KNew position23.7K after2 lots
Dec 19, 2023 (view filing)7:09 PM ETDec 15-194 daysPuhlmann MarkusChief Medical OfficerPPurchase+595.4K$0.317+$188.7K+119.1%1.10M after3 lots
Dec 18, 2023 (view filing)4:16 PM ETDec 14-154 daysWoods Lori ADirectorPPurchase+185.2K$0.2699+$50.0K+13.9%1.52M after2 lots
Dec 5, 2022 (view filing)6:09 PM ETDec 1-54 daysHunt Jonathan RobertChief Financial OfficerPPurchase+85.4K$0.3806+$32.5K+80.3%191.7K after2 lots
Nov 17, 2022 (view filing)6:43 PM ETNov 152 daysWoods Lori ACEOPPurchase+100.0K$0.3354+$33.5K+9.6%1.15M after
Jun 9, 2022 (view filing)8:24 PM ETJun 8-91 dayAustin Mark JohnVP Finance/Prin Fin&Acct OfficPPurchase+18.8K$0.2864+$5.38K+53.4%54.0K after2 lots
Jun 9, 2022 (view filing)5:20 PM ETJun 72 daysWoods Lori ACEOPPurchase+75.0K$0.2964+$22.2K+7.7%1.05M after
Jun 9, 2022 (view filing)5:18 PM ETJun 7-82 daysHunt Jonathan RobertChief Financial OfficerPPurchase+39.0K$0.2862+$11.2K+57.9%106.3K after2 lots